 MINNEAPOLIS, April 15, 2021 PRNewswire -- Bio-Techne Corporation NASDAQ: TECH today announced that Advanced Cell Diagnostics ACD, a Bio-Techne brand, completed an extensive rebranding effort in response to increased demand for its Assay Services offered at its Newark, CA laboratory. At the heart of this re-launch is a name change from Pharma Assay Services to Professional Assay Services, with an expansion of offerings to global academic and clinical institutions, building on 10 years of experience providing services to our global pharma and biotech partners. 